Thompson Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Thompson Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.3K	Hold	291	–	–	0.01%	266
2026 Q1	$49.1K	Hold	291	–	–	0.01%	274
2025 Q4	$49.1K	Hold	291	–	–	0.01%	277
2025 Q3	$42K	Hold	291	–	–	0.01%	297
2025 Q2	$36.8K	Hold	291	–	–	0.01%	308
2025 Q1	$37.2K	Hold	291	–	–	0.01%	299
2024 Q4	$38.5K	Hold	291	–	–	0.01%	301
2024 Q3	$42.4K	Hold	291	–	–	0.01%	275
2024 Q2	$39.9K	Hold	291	–	–	0.01%	275
2024 Q1	$39.9K	Hold	291	–	–	0.01%	288
2023 Q4	$39.5K	Hold	291	–	–	0.01%	248
2023 Q3	$35.6K	Hold	291	–	–	0.01%	257
2023 Q2	$36.9K	Hold	291	–	–	0.01%	261
2023 Q1	$37.6K	Buy	+291	New	+$38.1K	0.01%	266

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Thompson Investment Management's IBB Position: Q2 2026 in Review

Thompson Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 291 shares worth $55.3K. The position accounts for 0.01% of the portfolio, ranked #266.

Thompson Investment Management first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Thompson Investment Management held 291 shares of iShares Biotechnology ETF worth $55.3K as of Q2 2026.
Thompson Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Thompson Investment Management's portfolio in Q2 2026, its #266 holding.
Thompson Investment Management first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.